Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of HCA Healthcare, Inc. NYSE: HCA. In a filing disclosed on March 27th, the Representative disclosed that they had sold between $1,001 and $15,000 in HCA Healthcare stock on February 25th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 3/7/2025.
- Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/6/2025.
- Purchased $1,001 - $15,000 in shares of SEA NYSE: SE on 3/5/2025.
- Sold $1,001 - $15,000 in shares of Credo Technology Group NASDAQ: CRDO on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Twilio NYSE: TWLO on 3/4/2025.
- Sold $15,001 - $50,000 in shares of Alibaba Group NYSE: BABA on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Zoom Video Communications NASDAQ: ZM on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Intel NASDAQ: INTC on 3/3/2025.
- Purchased $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 3/3/2025.
HCA Healthcare Price Performance
NYSE:HCA traded up $0.78 during mid-day trading on Wednesday, reaching $346.51. The stock had a trading volume of 315,697 shares, compared to its average volume of 1,344,359. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The stock has a market capitalization of $85.31 billion, a PE ratio of 15.77, a P/E/G ratio of 1.10 and a beta of 1.68. The stock has a 50-day simple moving average of $325.79 and a two-hundred day simple moving average of $340.25.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the company earned $5.90 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a dividend of $0.72 per share. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.83%. The ex-dividend date was Monday, March 17th. HCA Healthcare's payout ratio is currently 13.11%.
Analyst Ratings Changes
A number of brokerages have commented on HCA. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Royal Bank of Canada lowered their price target on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a report on Monday, January 27th. Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Finally, Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $385.67.
Get Our Latest Report on HCA
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.30% of the company's stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the business. Whipplewood Advisors LLC bought a new position in HCA Healthcare during the fourth quarter valued at $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth $36,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the third quarter valued at about $39,000. Activest Wealth Management increased its position in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after purchasing an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. increased its holdings in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after buying an additional 50 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
About HCA Healthcare
(
Get Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
